Moderna names its price for Covid-19 vaccine; a flurry of pharma acquisitions kick off JPM week

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

STAT+: Moderna plans to follow in Pfizer's footsteps, charge up to $130 for Covid-19 vaccine in U.S. By Ed Silverman Steve Helber/AP Moderna plans to price its Covid-19 vaccine at anywhere from $110 to $130 per dose as it shifts focus to commercial distribution in the U.S. Read More STAT+: A flurry of pharma acquisitions kick off JPM week after a slow year for deals By Jonathan Wosen and Allison DeAngelis Raphael Lafargue/Abaca/Sipa USA via AP Four life science companies have announced acquisitions worth roughly $4.5 billion in total, raising hopes that 2023 will yield more M&A. Read More STAT+: Regeneron's Eylea sales dip, as competition looms By Jason Mast Kristoffer Tripplaar/Sipa via AP Wall Street had been watching to see if biosimilars and other new rivals would cut into the huge sales of the macular degeneration drug Eylea. Read More Sponsored Insight by STAT Reports The potential for mRNA to transform the drug industry could extend well beyond its usefulness in infectious disease immunization vaccines The future of mRNA. mRNA is powering the next generation of gene editing technologies. Think of this STAT exclusive report as an introduction to a large, active, and fast-growing field. We'll delve into how researchers are working to harness mRNA in fighting cancer, replenishing missing proteins, and even rewriting our DNA, among other areas. By the end you should have a good grasp of where the field is and where it's going. Download the report here. STAT+: Novavax replaces CEO, citing need for 'fresh perspective' By Matthew Herper JUSTIN TALLIS/AFP via Getty Images After being chosen to be develop a Covid vaccine as part of Operation Warp Speed, Novavax hit manufacturing issues and regulatory roadblocks. Read More Telehealth abortion providers eye new options for patients under loosened FDA rules By Katie Palmer Alex Hogan/STAT Several telemedicine companies that provide medication abortion expressed enthusiasm for local pickup options under new FDA rules. Read More Monday, January 9, 2023       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2023, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser